Shearman Mark S
SEC CIK 1643799 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | EVP, CSO | 65.6K | — | $78.7K | 4 | 2021-12-22 | 2023-02-13 |
Most active insiders at EDIT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Neill Gilmore Neil | CEO, Dir | — | $80.0K |
| 2 | Burkly Linda | EVP, CSO | — | $20.3K |
| 3 | Parison Amy | SVP, CFO | — | $6,327 |
Shearman Mark S made no open-market trades at EDIT in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-15 | 2023-02-13 | EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CSO | S - Sale | $9.67 | -2,790 | 65.6K | -4% | -$27.0K | |
| 2022-06-16 | 2022-06-15 | EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CSO | S - Sale | $10.06 | -5,145 | 68.3K | -7% | -$51.8K | |
| D | 2022-02-11 | 2022-02-10 | EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CSO | A - Grant | $0.00 | +31.7K | 73.5K | +76% | $0 |
| 2021-12-23 | 2021-12-22 | EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CSO | A - Grant | $0.00 | +9,084 | 41.8K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations